1.Potential Targeting of Siglecs, Mast Cell Inhibitory Receptors, in Interstitial Cystitis.
Chang Shin PARK ; Bruce S BOCHNER
International Neurourology Journal 2011;15(2):61-63
Mast cell increases and activation are detected in the chronic inflammatory bladder disease interstitial cystitis (IC), and their proinflammatory mediators are felt to contribute to regional pelvic pain and inflammatory pathophysiology. The immunoreceptor tyrosine-based inhibition motif-containing sialic acid-binding immunoglobulin-like lectins (Siglecs) expressed in mast cells could be evaluated as in vivo signaling regulators capable of inhibiting IC-related mast cell activation.
Cystitis, Interstitial
;
Lectins
;
Mast Cells
;
Pelvic Pain
;
Sialic Acid Binding Immunoglobulin-like Lectins
;
Urinary Bladder
;
Urinary Bladder Diseases
2.Eosinophil Survival and Apoptosis in Health and Disease.
Yong Mean PARK ; Bruce S BOCHNER
Allergy, Asthma & Immunology Research 2010;2(2):87-101
Eosinophilia is common feature of many disorders, including allergic diseases. There are many factors that influence the production, migration, survival and death of the eosinophil. Apoptosis is the most common form of physiological cell death and a necessary process to maintain but limit cell numbers in humans and other species. It has been directly demonstrated that eosinophil apoptosis is delayed in allergic inflammatory sites, and that this mechanism contributes to the expansion of eosinophil numbers within tissues. Among the proteins known to influence hematopoiesis and survival, expression of the cytokine interleukin-5 appears to be uniquely important and specific for eosinophils. In contrast, eosinophil death can result from withdrawal of survival factors, but also by activation of pro-apoptotic pathways via death factors. Recent observations suggest a role for cell surface death receptors and mitochondria in facilitating eosinophil apoptosis, although the mechanisms that trigger each of these death pathways remain incompletely delineated. Ultimately, the control of eosinophil apoptosis may someday become another therapeutic strategy for treating allergic diseases and other eosinophil-associated disorders.
Apoptosis
;
Cell Count
;
Cell Death
;
Eosinophilia
;
Eosinophils
;
Hematopoiesis
;
Humans
;
Interleukin-5
;
Mitochondria
;
Proteins
;
Receptors, Death Domain
3.Eosinophil Survival and Apoptosis in Health and Disease.
Yong Mean PARK ; Bruce S BOCHNER
Allergy, Asthma & Immunology Research 2010;2(2):87-101
Eosinophilia is common feature of many disorders, including allergic diseases. There are many factors that influence the production, migration, survival and death of the eosinophil. Apoptosis is the most common form of physiological cell death and a necessary process to maintain but limit cell numbers in humans and other species. It has been directly demonstrated that eosinophil apoptosis is delayed in allergic inflammatory sites, and that this mechanism contributes to the expansion of eosinophil numbers within tissues. Among the proteins known to influence hematopoiesis and survival, expression of the cytokine interleukin-5 appears to be uniquely important and specific for eosinophils. In contrast, eosinophil death can result from withdrawal of survival factors, but also by activation of pro-apoptotic pathways via death factors. Recent observations suggest a role for cell surface death receptors and mitochondria in facilitating eosinophil apoptosis, although the mechanisms that trigger each of these death pathways remain incompletely delineated. Ultimately, the control of eosinophil apoptosis may someday become another therapeutic strategy for treating allergic diseases and other eosinophil-associated disorders.
Apoptosis
;
Cell Count
;
Cell Death
;
Eosinophilia
;
Eosinophils
;
Hematopoiesis
;
Humans
;
Interleukin-5
;
Mitochondria
;
Proteins
;
Receptors, Death Domain